Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Endocrinology|April 9, 2005
The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngiomaPat Kendall-Taylor, Peter J Jönsson, Roger Abs, et al.
European Journal of Endocrinology|April 3, 2003
Update on the diagnosis of GH deficiency in adultsRoger Abs
European Journal of Endocrinology|November 8, 2012
Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegalyJohan Verhelst, Brigitte Velkeniers, Dominique Maiter, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2005
Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database)Johan Verhelst, Pat Kendall-Taylor, Eva Marie Erfurth, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 20, 2005
Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS databaseRoger Abs, Anders F Mattsson, Bengt-Ake Bengtsson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database)Mitchell Geffner, Michael Lundberg, Maria Koltowska-Häggström, et al.
The Journal of Clinical Endocrinology and Metabolism|October 14, 2017
Relative Risks of Contributing Factors to Morbidity and Mortality in Adults With Craniopharyngioma on Growth Hormone ReplacementKevin C J Yuen, Anders F Mattsson, Pia Burman, et al.
Pituitary|May 29, 2007
Remission of acromegaly following long-term therapy with cabergoline: report of two casesJohan A Verhelst, Pascale J Abrams, Roger Abs
Acta Cardiologica|February 21, 2006
Cardiomyopathy and thyrotoxicosis: tachycardiomyopathy or thyrotoxic cardiomyopathy?Tom Vydt, Johan Verhelst, Gilles De Keulenaer
European Journal of Endocrinology|September 26, 2007
Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegalyGuy T'Sjoen, Marie Bex, Dominique Maiter, et al.
Pageof 4